Who owns the EXCALIBUR PHARMACEUTICALS trademark?

The EXCALIBUR PHARMACEUTICALS trademark is owned by Excalibur Pharmaceuticals, Inc..

What class is the EXCALIBUR PHARMACEUTICALS trademark registered in?

The EXCALIBUR PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EXCALIBUR PHARMACEUTICALS?

The USPTO serial number for EXCALIBUR PHARMACEUTICALS is 88624847.

What is the registration number for EXCALIBUR PHARMACEUTICALS?

EXCALIBUR PHARMACEUTICALS is registered under USPTO registration number 7626610.

EXC

USPTO Trademark Record

REGISTERED

EXCALIBUR PHARMACEUTICALS

SN 88624847·Reg 7626610·Filed Sep 20, 2019

Owner Excalibur Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EXCALIBUR PHARMACEUTICALS (Serial No. 88624847), Registration No. 7626610, is a registered US trademark filed on Sep 20, 2019 by Excalibur Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: December 24, 2030

Mark Intelligence

EXCALIBUR PHARMACEUTICALS (Reg. #7626610) is a registered US trademark that has been protecting its owner, Excalibur Pharmaceuticals, Inc., since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 20, 2019

SERIAL

88624847

REG#

7626610

REGISTERED

Dec 24, 2024

Owner

Applicant

Excalibur Pharmaceuticals, Inc.

Entity

Corporation

State

Address

9 Sniffen Court, New York, NY, 10016

Country

Attorney

NameChristina M. Licursi

Law firm

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

Docket

C16032000000

Address

600 ATLANTIC AVENUE, BOSTON, MA 02210-2206, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 20, 2019

Serial Number88624847

Registration No.7626610

Registration DateDec 24, 2024

Status DateDec 24, 2024

Published for OppositionFeb 09, 2021

Mark TypeStandard characters

Attorney DocketC16032000000

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Feb 08, 2022

First use in commerce: Feb 08, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

56 events

REGISTERED-PRINCIPAL REGISTER

Dec 24, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 24, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Dec 05, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Dec 05, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO LIE

Nov 04, 2024

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 04, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 04, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 08, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 08, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

May 08, 2024

NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

May 08, 2024

SU - NON-FINAL ACTION - WRITTEN

STATEMENT OF USE PROCESSING COMPLETE

Apr 16, 2024

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Apr 08, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Apr 08, 2024

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 06, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 05, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Sep 05, 2023

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Aug 28, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Aug 28, 2023

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 06, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 04, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Apr 04, 2023

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Apr 04, 2023

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 08, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 06, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Oct 06, 2022

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Oct 06, 2022

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 08, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Apr 06, 2022

SOU EXTENSION 2 GRANTED

SOU EXTENSION 2 FILED

Apr 06, 2022

SOU EXTENSION 2 FILED

SOU TEAS EXTENSION RECEIVED

Apr 06, 2022

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 01, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 29, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 29, 2021

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 29, 2021

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 06, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 09, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 09, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 20, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 07, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 06, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Jan 06, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 06, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NOTIFICATION OF FINAL REFUSAL EMAILED

Jul 10, 2020

NOTIFICATION OF FINAL REFUSAL EMAILED

FINAL REFUSAL E-MAILED

Jul 10, 2020

FINAL REFUSAL E-MAILED

FINAL REFUSAL WRITTEN

Jul 10, 2020

FINAL REFUSAL WRITTEN

DATA MODIFICATION COMPLETED

Jun 30, 2020

DATA MODIFICATION COMPLETED

ASSIGNED TO LIE

Jun 29, 2020

ASSIGNED TO LIE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 06, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 05, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 05, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Jan 02, 2020

NON-FINAL ACTION WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 02, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Jan 02, 2020

NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 20, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 26, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

EXCALIBUR PHARMACEUTICALS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Christina M. Licursi

Industries

USPTO Deadlines

Compare

Resources

Company